Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents

European Journal of Endocrinology

Volumn 134, Issue 2, 1996, Pages 184-189

  Hasegawa, Yukihiro ^a,d   Hasegawa, Tomonobu ^a   Takada, Makoto ^b   Tsuchiya, Yutaka ^c  

^a Div of Endocrinology and Metabolism   (Japan)

^b Research Center   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d Div of Endocrinology and Metabolism   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNORADIOMETRIC ASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 0030060210     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340184     Document Type: Article

References (44)

1. Baxter RC. The somatomedins: insulin-like growth factors. Adv Clin Chem 1986;25:49-115
2. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structure, serum, and tissue concentrations. Endocr Rev 1989;10:68-91
3. Cohen, P. Fielder PJ, Hasegawa Y, Frishe H, Guidice LC, Rosenfeld RG. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenh) 19;124:74-85
4. Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimates of half lives and production rates. Acta Endocrinol (Copenh) 1989;121:753-8
5. Takada M, Nakanome H, Kohsida M, Hirose S, Hasegawa T, Hasegawa Y. Measurements of free IGF-I using immunoradiometric assay. J Immunoassay 1994;15(3):263-76
6. Hasegawa Y, Takada M, Hasegawa T, Tsuchiya Y. Clinical utility of newly developed free Insulin-like growth factor-I measurements by IRMA [Abstract]. Clin Pediatr Endocrinol 1994;3 Suppl 5:160-1
7. Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S. Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol 1992;1:5-11
8. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Araki K, Ohyama Y, et al. Comparison between IGF-I and IGFBP-3 measurements in the diagnosis of growth hormone deficiency. Endocr J 1993;40:185-90
9. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y, Nose O, et al. Usefulness and limitation of measurement of IGFBP-3 for diagnosis of growth hormone deficiency. Endocrinol Jn 1992;39:585-91
10. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y, et al. Clinical utility of insulin-like growth factor binding protein 3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol 1994;131:27-32
11. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-8
12. Hasegawa Y, Hasegawa T, Kotoh S, Tsuchiya Y. Ratio of false positive results of GH stimulation tests (arginine and insulin). Clin Pediatr Endocrinol Suppl 1993;2:65-7
13. Frasier SD. A review of growth hormone stimulation tests in children. Pediatrics 1974;53:929-37
14. Root AW, Rosenfield RL, Bongiovanni AM, Everlein WR. The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics 1967;39:844-52
15. Parker ML, Hammond JM, Daughghaday WH. The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J Clin Endocrinol 1967;27:1129-36
16. Raiti S, Davis WT, Blizzard RM. A comparison of the effects of insulin hypoglycemia and arginine infusion on release of human growth hormone. Lancet 1967;2:1182-3
17. Kaplan SL, Abrams CAL, Bell JJ, Conte FA, Grumbach MM. Growth and growth hormone: changes in serum level of growth hormone following hypoglycemia in disorders of growth. Pediatr Res 1968;2:43-63
18. Root AW, Saenz-Rodriguez C, Bongiovaani AM, Everlein WR. The effect of argmine infusion on plasma growth hormone and insulin in children J Pediatr 1969;74:187-97
19. Penny R, Blizzard RM, Davis WT. Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab 1969;29:1499-501
20. Hasegawa Y, Hasegawa T, Kotoh S, Tsuchiya Y. Reproducibility of GH stimulation tests (arginine and insulin). IGF-I and IGFBP-3 measurements. Clin Peldiatr Endocrino Suppl 1993;2:75-8
21. Donaldson DL, Pan F, Hollowell JG, Stevenson JL, Gifford RA, Moore WV. Reliability of stimulated and spontaneous GH levels for identifying the child with low GH secretion. J Clin Endocrinol Metab 1991;72:647-52
22. Zadik Z, Chalew SA, Kowarski AA. Reproducibility of growth hormone testing procedures: quantitative comparison between 24-hour integrated concentration and pharmacological stimulation. J Clin Endocrinol Metab 1990;71:117-30
23. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL. et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-40
24. Harada S, Yuri K, Okuno A, Hosoda A, Fujieda K, Matsuura N. Basic and clinical study of human growth hormone immunoradiometric assay (in Japanese). Med Pharmacol 1989;22(1): 189-93
25. Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y, Nose O, et al. Clinical utility of serum IGFBP-3 measurements in the diagnosis of GH deficiency. Hormone-to-Rinsyou 1992;40 (3):213-6 (in Japanese)
26. Hasegawa Y, Hasegawa T, Koni N, Aso T, Tanaka N, Kotoh S, et al. Proteolytic activity of IGFBP-3 in various clinical conditions during childhood by means of western immunoblotting. Endo J
27. Guler HP, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987;317:137-40
28. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal hypophysectomized rats. J Clin Invest 1986;77:1768-75
29. Hizuka N, Takano K, Asakawa K, et al. Measurement of free form of insulin-like growth factor I in human plasma. Growth Regul 1991;1:51-5
30. Adughaday WH, Ward AP, Goldberg AC, Trivedi B, Kapadia M. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J Clin Endocrinol Metab 1982;55:916-21
31. Chatelain PG, Van Wyk JJ, Copeland KC, Blethen SL. Underwood LE. Effect of in vivo action of serum protease or exposure of acid on measurable immunoreactive somatomedin-C in serum. J Clin Endocrinol Metab 1982;55:376-83
32. Lieberman SA, Bukar J. Chen Sam Celniker AC, Compton PG, Cook J, Albu J, et al. J Clin Endocrinol Metab 1992;75:30-6
33. Lee PDK, Powell DR, Baker B, Liu F, Mathew G, Levitsky I, et al. Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I. 76th Annu Meet Endocr Soc. Anaheim. 1994. Abstract
34. Frystyk J, Skjaebaek C, Dinesen Bo, Orskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 1994;348:185-91
35. Lewitt MS, Saunders H, Baxter RC. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 1993;133:1797-802
36. Lewitt MS, Saunder H, Phuyal JL, Baxter RC. Complex formation by Human Insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology 1994;134:2404-9.
37. Bang P, Brismar K, Rosenfeld RG. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFGP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-KDa glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab 1994;78:1119-27
38. Underwood LE, D'Ercole AJ, Van Wyke JJ. Somatomedin-C and the assessment of growth. Pediatr Clin North Am 1980;27:771-82
39. Fielder PJ, Thordarson G, Talamates F, Rosenfeld RG. Characterization on Insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and IGFBP-specific serum protease activity. Endocrinology 1990;127:2270-80
40. Guidice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. Insulin-like growth factor binding proteins in maternal serum throughout gestation and on the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 1990;71:806-16
41. Hosselopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab 1990;71:797-805
42. Hasegawa T, Hasegawa Y, Takada M, Tsuchiya Y. The free form of Insulin-like growth factor-I increases in circulation during normal human pregnancy. J Clin Endocrinol Metab. 1995. In press
43. Cotterill AM, Holly JMP, Taylor AM, Daws SC, Coulson VJ, Preece MA, et al. The insulin-like growth factor (IGF) - binding proteins and IGF bioactivity in Laron-type dwarfism. J Clin Endocrinol Metabol 1992;74:56-63
44. Gargosky SE, Hasegawa T, Tapanainen P, Macgillivray M, Hasegaw Y, Rosenfiaeld RG. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease. J Clin Endocrinol Metab 1993;76:1631-7